Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthcare Services (HCSG) Short term Debt (2022 - 2024)

Historic Short term Debt for Healthcare Services (HCSG) over the last 3 years, with Q3 2024 value amounting to $25.0 million.

  • Healthcare Services' Short term Debt fell 4444.44% to $25.0 million in Q3 2024 from the same period last year, while for Sep 2024 it was $25.0 million, marking a year-over-year decrease of 4444.44%. This contributed to the annual value of $25.0 million for FY2023, which is 0.0% changed from last year.
  • Healthcare Services' Short term Debt amounted to $25.0 million in Q3 2024, which was down 4444.44% from $30.0 million recorded in Q2 2024.
  • Over the past 5 years, Healthcare Services' Short term Debt peaked at $45.0 million during Q3 2023, and registered a low of $10.0 million during Q1 2022.
  • Moreover, its 3-year median value for Short term Debt was $25.0 million (2022), whereas its average is $28.2 million.
  • Its Short term Debt has fluctuated over the past 5 years, first surged by 30000.0% in 2023, then crashed by 4444.44% in 2024.
  • Over the past 3 years, Healthcare Services' Short term Debt (Quarter) stood at $25.0 million in 2022, then changed by 0.0% to $25.0 million in 2023, then changed by 0.0% to $25.0 million in 2024.
  • Its Short term Debt stands at $25.0 million for Q3 2024, versus $30.0 million for Q2 2024 and $40.0 million for Q1 2024.